TNFRSF17 and neoplasm: BCMA expression on tumor-associated endothelial cells [26], keratinocytes [27] and adipocytes [28] has also been reported in the literature, making thorough evaluation of the tissue distribution imperative for translation of therapies targeting this molecule into the clinical setting.